Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Century Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 65 | 57 | −8 |
| Shares | 22.6M | 20.3M | −2.31M (−10.2%) |
| Value | $12.6M | $10.1M | −$2.52M (−19.9%) |
New holders (5)
Institutions that held Century Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 27,558 | $13.7K | 0.00% |
| Bluefin Capital Management, LLC | 24,018 | $12.0K | 0.01% |
| Advisory Services Network, LLC | 407 | $203 | 0.00% |
| SRS Capital Advisors, Inc. | 99 | $49 | 0.00% |
| Optiver Holding B.V. | 32 | $16 | 0.00% |
Sold out (13)
Institutions that held Century Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Charles Schwab Investment Management Inc | 163,377 | $91.3K |
| Y-Intercept (Hong Kong) Ltd | 89,975 | $50.3K |
| Lazard Asset Management LLC | 62,947 | $35.0K |
| Bridgeway Capital Management, LLC | 26,700 | $14.9K |
| Ieq Capital, LLC | 22,419 | $12.5K |
| Abel Hall, LLC | 17,582 | $9.82K |
| Two Sigma Securities, LLC | 11,767 | $6.57K |
| Ground Swell Capital, LLC | 10,176 | $5.68K |
| The PNC Financial Services Group, Inc. | 6,274 | $3.51K |
| Cubist Systematic Strategies, LLC | 1,978 | $1.10K |
| Wells Fargo & Company | 861 | $481 |
| True Wealth Design, LLC | 266 | $149 |
| Essential Partners LLC | 119 | $66 |